Founder and CEO of US online social media and social networking service Facebook Mark Zuckerberg. Photo by KENZO TRIBOUILLARD/AFP via Getty Images/FILE)
Mark Zuckerberg and his wife Priscilla Chan have donated $25 million through their foundation to a philanthropic effort organized by Bill Gates to explore new coronavirus treatments.
The Gates Foundation donated $50 million last week to what it’s calling the “COVID-19 Therapeutics Accelerator.” The initiative brings together life sciences companies to collaborate on the development of new vaccines, diagnostics, and treatments for COVID-19.
“The Therapeutics Accelerator will enable researchers to quickly determine whether or not existing drugs have a potential benefit against COVID-19,” Chan and Zuckerberg said in a press release. “We hope these coordinated efforts will help stop the spread of COVID-19 as well as provide shared, reusable strategies to respond to future pandemics.”
The two donations are the largest from tech billionaires since the coronavirus outbreak. Wellcome and Mastercard are supporting the effort as well.
The goal of the initiative is to either develop a new drug or adapt an existing treatment that it could help distribute alongside partnering pharmaceutical companies.
The 15 companies participating in the project kicked off the effort by sharing their proprietary libraries of molecular compounds that have some history of being tested with COVID-19.
The lineup includes big names in biotech such as Johnson & Johnson, Merck, Pfizer, Sanofi, and Bristol-Myers Squibb.
Enterprise blockchain provider, BlockApps, recently raised $41 million in a new funding round led by Liberty City Ventures. BlockApps builds products and applications for other companies on its own blockchain platform called STRATO. The company says its blockchain technology can help businesses increase the value of their assets, streamline their supply chains, and help them meet their sustainability goals. Kieren James-Lubin, President & CEO of BlockApps, joins Cheddar News' Closing Bell to discuss.
Tesla has continued to beat expectations as illustrated by its last quarter earnings despite issues in Shanghai, China. Dan Ives, the managing director of equity research at Wedbush Securities, joined Cheddar News to talk about the resilience of Tesla. "I thought they were almost Cinderella-like numbers," he said about the delivery numbers. "They are performing just miles ahead of any auto player, and that's why the stock is doing what it's doing. In my opinion, they're expanding their lead in EVs, even in this Category 5 hurricane that we're seeing in China." Ives noted that issues in China could pose ongoing challenges going forward even with the largely positive outlook.
Dr. Neta Lavon, CTO and VP of R&D at Aleph Farms, joins Cheddar Innovates to discuss how the team sent cow cells to space to further research the production of meat in space, and why developing cultivated meat is so critical to the future of space travel.
A new report from DrakeStar Partners, an investment bank that closely tracks the sector, said $98.7 billion in deals were announced or closed in the first three months of the year. T
AT&T reported a 2.5 percent rise in its core wireless revenue for the first quarter as its 5G rollout expands across the United States, even as the company pivots away from streaming to focus on its communication business amid heightened demand for high-speed internet. CEO John Stankey joined Cheddar's Opening Bell to discuss the company's 5G plans, its divestment from WarnerMedia, and its push into the metaverse. "To the extent that we start to see social aspects come into the metaverse that allows people to — as they're out and about — experience those kinds of things, that just puts a higher premium on mobile networks and scaled robust mobile networks to enable those applications, which is our bread and butter, and it's probably one of our best returning and best yielding businesses," he said.
